Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibodies to a Full-Length VAR2CSA Immunogen Are Broadly Strain-Transcendent but Do Not Cross-Inhibit Different Placental-Type Parasite Isolates
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 2, Pages e16622
Publisher
Public Library of Science (PLoS)
Online
2011-02-08
DOI
10.1371/journal.pone.0016622
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of the Antigenic Diversity of Placenta-Binding Plasmodium falciparum Variants and the Antibody Repertoire among Pregnant Women
- (2010) M. Hommel et al. INFECTION AND IMMUNITY
- Immunization with VAR2CSA-DBL5 Recombinant Protein Elicits Broadly Cross-Reactive Antibodies to Placental Plasmodium falciparum-Infected Erythrocytes
- (2010) M. Avril et al. INFECTION AND IMMUNITY
- IgM, Fc Rs, and Malarial Immune Evasion
- (2010) D. M. Czajkowsky et al. JOURNAL OF IMMUNOLOGY
- Full-Length Recombinant Plasmodium falciparum VAR2CSA Binds Specifically to CSPG and Induces Potent Parasite Adhesion-Blocking Antibodies
- (2010) Pongsak Khunrae et al. JOURNAL OF MOLECULAR BIOLOGY
- Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodies
- (2010) Ali Salanti et al. MALARIA JOURNAL
- Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA
- (2010) A. Srivastava et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Induction of Adhesion-Inhibitory Antibodies against Placental Plasmodium falciparum Parasites by Using Single Domains of VAR2CSA
- (2009) M. A. Nielsen et al. INFECTION AND IMMUNITY
- Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites
- (2009) Mafalda Resende et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Structural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during Pregnancy
- (2009) Pongsak Khunrae et al. JOURNAL OF MOLECULAR BIOLOGY
- Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris
- (2009) Marion Avril et al. MALARIA JOURNAL
- An In Vivo and In Vitro Model of Plasmodium falciparum Rosetting and Autoagglutination Mediated by varO, a Group A var Gene Encoding a Frequent Serotype
- (2008) I. Vigan-Womas et al. INFECTION AND IMMUNITY
- Evidence for Globally Shared, Cross-Reacting Polymorphic Epitopes in the Pregnancy-Associated Malaria Vaccine Candidate VAR2CSA
- (2008) M. Avril et al. INFECTION AND IMMUNITY
- The Structure of a Chondroitin Sulfate-binding Domain Important in Placental Malaria
- (2008) Matthew K. Higgins JOURNAL OF BIOLOGICAL CHEMISTRY
- VAR2CSA Expression on the Surface of Placenta‐DerivedPlasmodium falciparum–Infected Erythrocytes
- (2008) Pamela Magistrado et al. JOURNAL OF INFECTIOUS DISEASES
- VAR2CSA Domains Expressed inEscherichia coliInduce Cross‐Reactive Antibodies to Native Protein
- (2008) Andrew V. Oleinikov et al. JOURNAL OF INFECTIOUS DISEASES
- Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites
- (2008) Pablo Fernandez et al. MALARIA JOURNAL
- Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A
- (2008) Kavita Singh et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA
- (2008) Pernille Andersen et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More